Effect of Posterior TAP Block on ANI-Guided Remifentanil Consumption in Gynecologic Laparotomy
Effect of Preoperative Posterior Transversus Abdominis Plane Block on Intraoperative Remifentanil Consumption Under Analgesia Nociception Index Guidance in Gynecologic Laparotomy: A Prospective, Randomized Controlled Trial
The aim of this study is to evaluate the effect of preoperative posterior transversus abdominis plane (TAP) block on intraoperative remifentanil consumption in patients undergoing gynecological laparotomy under Analgesia Nociception Index (ANI)-guided general anesthesia.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
A standardized anesthesia and analgesia protocol will be applied to all participants undergoing elective gynecological laparotomy. Participants will be randomly divided into two groups: those receiving preoperative ultrasound-guided bilateral posterior transversus abdominis plane (TAP) block and those without block. Intraoperative monitoring will include heart rate, noninvasive mean arterial pressure, oxygen saturation, Analgesia Nociception Index (ANI), and Bispectral Index (BIS). Remifentanil infusion will be adjusted according to ANI values, with a target range of 50-70. Intraoperative remifentanil consumption and postoperative analgesia will be compared between the two groups.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Sevda Akdeniz
- Telefonnummer: +90 505 399 86 51
- E-mail: akdenizsevda@yahoo.com
Undersøgelse Kontakt Backup
- Navn: Emre C Soydan
- Telefonnummer: +905366422896
- E-mail: emrecansoydanmd@gmail.com
Studiesteder
-
-
-
Samsun, Tyrkiet (Türkiye)
- Samsun University - Samsun Education and Research Hospital
-
Kontakt:
- Sevda Akdeniz
- Telefonnummer: +90 505 399 86 51
- E-mail: akdenizsevda@yahoo.com
-
Kontakt:
- Emre C Soydan
- Telefonnummer: +905366422896
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Female patients aged 18 to 70 years
- Scheduled for elective gynecologic laparotomy under general anesthesia
- ASA physical status I to III
- Planned perioperative management according to the study protocol
- Written informed consent obtained
Exclusion Criteria:
- Refusal to participate
- Contraindication to posterior transversus abdominis plane block
- Allergy or hypersensitivity to local anesthetic agents or study medications
- Coagulopathy or ongoing anticoagulant therapy that precludes regional anesthesia
- Infection at the planned block site
- Body mass index greater than 35 kg/m2
- Chronic opioid use
- Pregnancy
- Inability to understand the pain scoring system or use patient-controlled analgesia
- Conversion to a surgical procedure outside the planned gynecologic laparotomy protocol
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Posterior TAP Block Group
Participants in this group will receive preoperative ultrasound-guided bilateral posterior transversus abdominis plane (TAP) block in addition to standardized general anesthesia. Intraoperative remifentanil infusion will be adjusted according to ANI values, targeting a range of 50-70. |
Ultrasound-guided bilateral posterior transversus abdominis plane (TAP) block will be performed preoperatively in patients undergoing gynecological laparotomy. Bupivacaine 0.25% (2.5 mg/mL) will be administered as a single-shot, ultrasound-guided bilateral posterior transversus abdominis plane (TAP) block before surgery. A total volume of 40 mL (100 mg) will be administered, with 20 mL (50 mg) injected on each side. The intervention will be performed only in the experimental group. |
|
Ingen indgriben: Control Group
Participants in this group will not receive a TAP block. Standardized general anesthesia will be administered, and intraoperative remifentanil infusion will be adjusted according to ANI values, targeting a range of 50-70. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Intraoperative Remifentanil Consumption
Tidsramme: Intraoperative period
|
Intraoperative remifentanil consumption will be calculated by dividing the total remifentanil dose by patient body weight and infusion duration, expressed in µg/kg/min. |
Intraoperative period
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Numeric rating scale for postoperative pain intensity
Tidsramme: up to 24 hours (Will be evaluated at 1, 3, 6, 9, 12, 18, 24 hours)
|
Evaluated with a Numerical rating scale (NRS) from 0 to 10. (0=no pain; 10=worst imaginable pain) |
up to 24 hours (Will be evaluated at 1, 3, 6, 9, 12, 18, 24 hours)
|
|
Quality of Recovery - 15 score
Tidsramme: Postoperative 24th hour
|
The impact of surgical and anesthetic interventions on perioperative quality of life and ability to resume routine life activities will be assessed using the Quality of Recovery (QoR) tool. Each question is scored between 0 and 10. The survey result varies between 0-150 points based on the answers given by the patients. Higher scores indicate better recovery. |
Postoperative 24th hour
|
|
Fentanyl consumption at 30 minutes after arrival in the PACU(post anesthesia care unit)
Tidsramme: 30 minutes
|
Postoperative pain will be assessed using the Numeric Rating Scale (NRS) from 0 to 10. Fentanyl will be administered when the NRS score is ≥4, and the total fentanyl consumption will be recorded in micrograms (µg). |
30 minutes
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Efterforskere
Efterforskere
- Ledende efterforsker: Sevda Akdeniz, Samsun University
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart (Anslået)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- OMUKAEK 2025/527
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .